about
IL-2 controls trafficking receptor gene expression and Th2 response for skin and lung inflammationEvaluation of a DLA-79 allele associated with multiple immune-mediated diseases in dogs.The clinical application value of cytokines in treating infectious diseases.Constrained release of lamina-associated enhancers and genes from the nuclear envelope during T-cell activation facilitates their association in chromosome compartments.Inflammation enhances IL-2 driven differentiation of cytolytic CD4 T cells.Loss of CNS IL-2 gene expression modifies brain T lymphocyte trafficking: response of normal versus autoreactive Treg-deficient T cells.Effect of malnutrition on the expression of cytokines involved in Th1 cell differentiationAutoimmunity in 2011.The autoimmune side of heart and lung diseases.Serum autoantibodies for the diagnosis and management of autoimmune liver diseases.Tregs: hype or hope for allogeneic hematopoietic stem cell transplantation?A review on interleukins: The key manipulators in rheumatoid arthritis.Dissecting the effects of endogenous brain IL-2 and normal versus autoreactive T lymphocytes on microglial responsiveness and T cell trafficking in response to axonal injury.Epidemiological characteristics and immune status of children with Respiratory Syncytial Virus.Deficiency of Nuclear Factor-κB c-Rel Accelerates the Development of Autoimmune Diabetes in NOD Mice.Regulatory T cells in Acute and Chronic Kidney Diseases.T cell subsets: an integral component in pathogenesis of rheumatic heart disease.
P2860
Q27022474-97A87F0D-DAE1-4E91-B5CE-2881EE1D25C8Q33428734-59A2A89B-41A9-4279-BB26-E8488A8C0F9CQ33700537-F077C4D6-F027-427A-9B73-9786079F123FQ33865147-FE4C0BB0-F157-4532-8CCE-8BCCAF96B6BCQ35106552-4A5079E4-2F94-4526-AD7E-F822917839FDQ35147178-A6E772CD-4035-436A-940F-356500BF7705Q36792421-867F4B30-AFDC-4BF4-A73B-2541CC15E12EQ38021696-F361E111-0E76-4B14-8FD0-387D1130237EQ38051261-16F41036-8C5A-4B7D-885F-2D6F3E03F0E0Q38067132-9155C500-6F48-40B1-A995-AA94CD2A7384Q38742863-9B75E4E0-7602-4775-9C17-19BE7A9D1F55Q39029629-0A3F6323-CAD0-4617-9AA9-A0F84C9A2311Q41680674-9B56176E-BA14-4631-B550-9250FFAAA464Q42199939-5C929B36-F738-4E9F-B7AE-1E2358DB4DA9Q42409234-413401F8-9F90-4DC0-A762-78F019BE481EQ45066685-13A5A49F-84D8-45D7-8400-563123AA7617Q47369105-699B30CB-41E2-4D26-88BD-5BDB6F6257F2
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
IL-2: a two-faced master regulator of autoimmunity
@ast
IL-2: a two-faced master regulator of autoimmunity
@en
type
label
IL-2: a two-faced master regulator of autoimmunity
@ast
IL-2: a two-faced master regulator of autoimmunity
@en
prefLabel
IL-2: a two-faced master regulator of autoimmunity
@ast
IL-2: a two-faced master regulator of autoimmunity
@en
P2860
P50
P1476
IL-2: a two-faced master regulator of autoimmunity
@en
P2860
P356
10.1016/J.JAUT.2011.01.001
P577
2011-02-01T00:00:00Z